A 12-month Open-label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures

Trial Profile

A 12-month Open-label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Dec 2014

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Partial epilepsies
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 20 Mar 2014 New trial record
    • 13 Nov 2013 The status of trial has changed to completed from recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top